Nafdac Pharmacovigilance/Post-Marketing Newsletter

pharmacovigilance/post-marketing newsletter, 2010 Vol 4 No 3

Adverse drug reactions (ADRs) attributable to the use of antibiotics constitute 7.59% of Individual Case Safety Reports (ICSR) received by the Nigerian National Pharmacovigilance Centre, through spontaneous reporting system as at September, 2010. This issue focuses on the reported adverse drug reactions (ADRs) attributable to use of antibiotics in the Nigerian population. Other features in this edition include; alerts, compilation of adverse drug reaction reports of interest as reported in “Reaction Weekly’’. Your comments and acknowledgement of receipt of this issue through our email would be most appreciated. Click for more...

pharmacovigilance/post-marketing newsletter, 2010 Vol 4 No 1

Adverse drug reactions (ADRs) attributable to antihypertensive medicines constitute 3.15% of Individual Case Safety Reports (ICSR) received by the Nigerian National Pharmacovigilance Centre, through spontaneous reporting system across the country as at March, 2010. This issue discusses the reported ADRs attributable to antihypertensive medicines. Other features in this edition include; compilation of adverse drug reaction reports of interest as reported in “Reaction Weekly”. Your comments and acknowledgement of receipt of this issue through our email would be most appreciated. Click for more...

pharmacovigilance/post-marketing newsletter, 2009 Vol 3 No 3

Adverse drug reactions (ADRs) attributable to antiretroviral medicines constitute 17% of Individual Case Safety Reports (ICSR) received by the Nigerian National Pharmacovigilance Centre, through spontaneous reporting system across the country as at September 2009. Consequently, this issue discuses the reported ADRs attributable to antiretroviral medicines and examines their specific toxicities. Other features of this Christmas edition include; compilation of adverse reaction reports of interest as reported in “Reaction Weekly” and alert notices. Your comments and acknowledgement of receipt of this issue through our email would be most appreciated. Click for more...